Malgorzata Wach, MD

Medical University of Lublin, Poland

Poster(s):

• 1424 - Safety Analysis of Fixed-Duration Acalabrutinib-Venetoclax Combinations vs Chemoimmunotherapy: A Post Hoc Analysis From the Phase 3 AMPLIFY Trial